Keckley Report September 21, 2020
Last week, four new reports lend credence to the likelihood that large investor owned health insurance companies will emerge from the pandemic as the big winners:
GoodRx analysis of prices across healthcare: The GoodRx Research Team compared data from the Bureau of Labor Statistics’ Consumer Price Index to its Drug List Price Index.
Key finding: since 2014, prescription drug prices have increased by 33%. During the same period, prices for other medical services increased less: inpatient hospital services (+30%), hospital outpatient services (+26%), nursing home care (+23%), dental services (+19%) and physician services (+10%) respectively. Nonprescription drugs aka over the counter (OTC) medications were the only service that has seen a drop in price since 2014 (-2%).
...
Today's Sponsors
Today's Sponsor